about
Evolution of genes and genomes on the Drosophila phylogenyCONTRAST: a discriminative, phylogeny-free approach to multiple informant de novo gene predictionEnvironmental influences on reproductive health: the importance of chemical exposuresTen years of pathway analysis: current approaches and outstanding challengesComputational repositioning of the anticonvulsant topiramate for inflammatory bowel disease.Relating hepatocellular carcinoma tumor samples and cell lines using gene expression data in translational researchAutoimmune disease classification by inverse association with SNP alleles.Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association.Identifying a high fraction of the human genome to be under selective constraint using GERP++.A Haystack Heuristic for Autoimmune Disease Biomarker Discovery Using Next-Gen Immune Repertoire Sequencing DataReversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targetsDiscovery and preclinical validation of drug indications using compendia of public gene expression data.Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.A systematic assessment of linking gene expression with genetic variants for prioritizing candidate targets.Transmission distortion in Crohn's disease risk gene ATG16L1 leads to sex difference in disease association.Effect of genome and environment on metabolic and inflammatory profilesSex differences in disease risk from reported genome-wide association study findings.Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes.Constraints on Biological Mechanism from Disease Comorbidity Using Electronic Medical Records and Database of Genetic VariantsUsing health-system-wide data to understand hepatitis B virus prophylaxis and reactivation outcomes in patients receiving rituximab.Systematic pan-cancer analysis of tumour purity.B cell exchange across the blood-brain barrier in multiple sclerosis.Cross-tissue Analysis of Gene and Protein Expression in Normal and Cancer Tissues.Germline-encoded neutralization of a Staphylococcus aureus virulence factor by the human antibody repertoireHydroxychloroquine dosing in immune-mediated diseases: implications for patient safety.Transplantomics: Toward Precision Medicine in Transplantation Research.Synergistic drug combinations from electronic health records and gene expression.Precision annotation of digital samples in NCBI's gene expression omnibus.A Classifier-based approach to identify genetic similarities between diseases.Identification of Alpha-Adrenergic Agonists as Potential Therapeutic Agents for Dermatomyositis through Drug-Repurposing Using Public Expression Datasets.Comprehensive analysis of normal adjacent to tumor transcriptomes.The role of bioinformatics in studying rheumatic and autoimmune disorders.Combined inhibition of atypical PKC and histone deacetylase 1 is cooperative in basal cell carcinoma treatment.Productive common light chain libraries yield diverse panels of high affinity bispecific antibodies.Drug Discovery in a Multidimensional World: Systems, Patterns, and Networks
P50
Q22122220-45124A77-B57A-4541-ABCD-6A918A680030Q24646173-47F80592-9A6C-432C-97F2-824CD39A679AQ28396514-FA048990-A985-4239-AC38-D52E75A33549Q29615564-E8FC0F18-910C-46E6-AA22-AAFB47FD53B8Q30526431-8AED1A03-6DDA-41D2-94D1-1FDD10502C27Q30965534-2259112F-1F5B-423A-8A60-0226841DBC6BQ33521311-6A5EC2C8-E2AA-451F-8BC7-F196629AA9E0Q33735944-50730CB4-B114-49E2-94C6-C4CD624DEFDCQ33735944-55BF4D35-B27B-4F7F-A445-F6B13869BB8DQ33769754-B767B8EC-DCD1-401E-B756-5DCEECD9CD65Q33902773-BFFE6426-2E16-4D34-812F-9E57D204AACBQ33903831-FB9F8FC1-C609-4F03-9867-30C234FE9BBDQ33995422-1A73F535-C52A-490E-9BA6-A2935B0757D6Q34251673-C20866EB-B45C-4927-9596-CA2942CBFEB5Q34988225-9C4B330B-2B27-4AE6-BB7C-1733320D8D66Q35190571-AAE1E05A-01A6-47B7-B404-090B7646359AQ35325431-CBAAA8F1-9249-4468-BB12-710AD197C890Q35678203-82759F8E-7E49-46C7-8187-AFD5BEB8D486Q35935710-47CB0F00-F15E-407C-8549-6D9FEB839E9AQ35999356-9CD70F8E-C9E1-4C5E-856C-4C08C1300A79Q36326450-6B0845C1-E99E-4C88-B560-5465BE52925BQ36350773-430526F2-B9A0-4023-834F-D16AC271ADB1Q36498036-AE3DA378-D026-4545-BC6E-540140AD7ED0Q36864774-CE7BF925-B183-410E-807D-06BA6429E194Q37430689-401DB36B-E7DF-4CD6-B680-A6EF1500228DQ38658480-0E021D21-35B5-4047-AA45-B92C0058051EQ38999814-7DE6D981-4ECC-4CBA-8F6B-5246C2A78DC8Q39111678-DFB6180A-F589-4281-A6DE-C9B656B841ABQ41678419-2E30D5F2-E2F1-4A57-82A8-3A24FD0BFA1DQ41808674-B2AF5675-F787-4934-B442-76E68D6094DCQ42290856-E61E71B7-AC87-4064-BEBF-4BC34A0295B6Q42544189-DBF02BD2-CE76-4692-B64C-EC5ABBF47C33Q46122721-AAA29495-F842-4208-9C6E-ED2D4BE2CBC5Q46767544-85D9BA58-4490-44C0-B538-0BA4103C5C47Q49951608-EDD6B1FB-E6D5-4038-8B10-A3D15E153ED6Q57999809-61AD6A85-BEBA-42BA-A64A-2A708A2D517E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marina Sirota
@ast
Marina Sirota
@en
Marina Sirota
@es
Marina Sirota
@nl
Marina Sirota
@sl
type
label
Marina Sirota
@ast
Marina Sirota
@en
Marina Sirota
@es
Marina Sirota
@nl
Marina Sirota
@sl
prefLabel
Marina Sirota
@ast
Marina Sirota
@en
Marina Sirota
@es
Marina Sirota
@nl
Marina Sirota
@sl
P106
P21
P31
P4012
P496
0000-0002-7246-6083